Physician profile
Ronald J Meyer
NPI 1760561864
$2,051.37
in general payments reported to CMS, 2019-2025
10 companies · $933 in 2025
The $933 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.80 · 2020: $104 · 2021: $82.46 · 2022: $163 · 2023: $258 · 2024: $430 · 2025: $933.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Food and Beverage: $620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Food and Beverage | $620.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,562.92 | 2019-2025 | Precision 1, Dailies Total1, Air Optix Color |
| Johnson & Johnson Vision Care, INC. | $111.44 | 2020-2023 | Acuvue |
| Lombart Brothers, INC. | $88.07 | 2022 | |
| Novartis Pharmaceuticals Corporation | $79.57 | 2019-2023 | |
| Lkc Technologies, INC. | $64.42 | 2024-2025 | |
| Coopervision INC. | $57.19 | 2023-2024 | Myday Contact Lens |
| Bausch & Lomb Americas INC. | $31.14 | 2023 | Infuse |
| Shire North American Group INC | $21.88 | 2019 | |
| Biotissue Holdings INC. | $19.44 | 2019-2020 | |
| Dompe US, INC. | $15.30 | 2024 | Oxervate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.